CCAL
GILD icon

City Center Advisors LLC’s Gilead Sciences GILD Stock Holding History

City Center Advisors LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,577
Closed -$423K – 166
2024
Q4 		$423K Sell
4,577
-2,020
-31% -$182K 0.47% 71
2024
Q3 		$553K Sell
6,597
-1,179
-15% -$90K 0.61% 40
2024
Q2 		$570K Hold
7,776
– – 0.67% 35
2024
Q1 		$570K Buy
+7,776
New +$598K 0.67% 35

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

City Center Advisors LLC's GILD Position: Q1 2025 in Review

City Center Advisors LLC sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 4,577 shares — an estimated $423K sold.

City Center Advisors LLC first reported a position in GILD in Q1 2024 and held it in 4 quarters. The position peaked at $570K in Q2 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • City Center Advisors LLC reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • City Center Advisors LLC sold 4,577 Gilead Sciences shares in Q1 2025, an estimated $423K.
  • City Center Advisors LLC first reported a position in Gilead Sciences in Q1 2024 and held it in 4 quarters.
  • City Center Advisors LLC's Gilead Sciences position peaked at $570K in Q2 2024.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on City Center Advisors LLC's 13F filing for Q1 2025, filed 14 Apr 2025.